At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Resilient Supply, with the mission of accelerating the advancement of cell and gene therapy (CGT) development. Mike Chen, Chairman, Founder, and CEO of ACROBiosystems Group, was in attendance to introduce the brand. Dr. Anil Kumar, […]
Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) today announced its participation in the FinnGen project, a large-scale research initiative at the forefront of personalized medicine in Finland. The FinnGen project is a pioneering endeavor that has collected and is currently analyzing genomic and health data from […]
SINGAPORE, Singapore — Agilent Technologies Inc. (NYSE: A) today announced the release of its new ProteoAnalyzer system, in addition to existing product updates at the Singapore Cell and Gene Therapy Pan Asia Summit (SCGT). Agilent’s new protein analysis platform, an automated parallel capillary electrophoresis (CE) solution, combines rapid, high-resolution analysis with minimal sample consumption. This allows researchers to examine complex […]
SAN FRANCISCO – Illumina Ventures, a leading genomics and precision health venture firm, today announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have joined the team as Advisors. Together, they bring more than 60 years of executive leadership experience in molecular diagnostics and agribusinesses, respectively. Dr. Stenzel is the former director of the US Food and […]
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the first patient has been dosed in Pure Biologics’ exploratory Phase […]
SEATTLE — Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced today the launch of the LuxSit™ Pro family of products, the world’s smallest and first commercially-available de novo luciferases, which are light-emitting enzymes that use proprietary chemical substrates. […]
SEATTLE — Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced today the launch of the LuxSit™ Pro family of products, the world’s smallest and first commercially-available de novo luciferases, which are light-emitting enzymes that use proprietary chemical substrates. The […]
BANGKOK — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today launched DNBSEQ-G400RS FluoXpert in the APAC region and opened early access to the platform at Medlab Asia & Asia Health 2024. Integrating high-throughput sequencing and multiplex immunofluorescence (mIF) staining, DNBSEQ-G400RS FluoXpert challenges conventions […]
Munich, Germany – NanoTemper Technologies is proud to announce a significant milestone in its journey toward excellence and innovation in the biotech industry. The company has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper Technologies’ commitment to fostering cutting-edge development while staying […]
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
